AL HB433 | 2023 | Regular Session
Status
Sponsorship: Partisan Bill (Republican 1)
Status: Introduced on May 3 2023 - 25% progression, died in chamber
Action: 2023-05-31 - Indefinitely Postpone
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on May 3 2023 - 25% progression, died in chamber
Action: 2023-05-31 - Indefinitely Postpone
Text: Latest bill text (Introduced) [PDF]
Summary
Relating to Opioid Addiction Treatment; to repeal the Medication Assisted Treatment of Opioid Use Act of 2019, codified as Sections 20-2-300 through 20-2-302, Code of Alabama 1975, that provide for adoption of rules governing use of buprenorphine in the treatment of opioid addiction and a standing working group to assist in drafting the rules.
Title
Relating to Opioid Addiction Treatment; to repeal the Medication Assisted Treatment of Opioid Use Act of 2019, codified as Sections 20-2-300 through 20-2-302, Code of Alabama 1975, that provide for adoption of rules governing use of buprenorphine in the treatment of opioid addiction and a standing working group to assist in drafting the rules.
Sponsors
History
| Date | Chamber | Action |
|---|---|---|
| 2023-05-31 | House | Indefinitely Postpone |
| 2023-05-18 | House | Substitute a Companion Bill |
| 2023-05-18 | House | On Third Reading in House of Origin |
| 2023-05-11 | House | Read Second Time in House of Origin |
| 2023-05-10 | House | Reported Out of Committee in House of Origin |
| 2023-05-10 | House | Reported Favorably from House Health |
| 2023-05-03 | House | Introduced and Referred to House Health |
| 2023-05-03 | House | Read First Time in House of Origin |
